C Ballouk

No ORCID on file · 1 paper in corpus
article 2023
·doi:10.1093/ajcp/aqad150.117

Abstract Introduction/Objective Borderline ovarian tumors (BOT) comprise approximately 15% of all primary ovarian neoplasms; of these endometroid borderline ovarian tumors (EBOT) are much rarer (2-3%). BOT is often potentially misdiagnosed …